Category Archives: Patient safety and outcomes
Idea Gallery is a recurring editorial series on NewPublicHealth in which guest authors provide their perspective on issues affecting public health. In this Idea Gallery, Brian C. Quinn, PhD, the Robert Wood Johnson Foundation’s Assistant Vice President, Research-Evaluation-Learning, provided his perspective on how to address medical conspiracies and other controversial narratives when developing a Culture of Health.
You may have recently seen the headline “Half of Americans believe in medical conspiracy theories”—or one like it—on your favorite news outlet. Or even on The Onion.
When the Robert Wood Johnson Foundation decided to fund the study responsible for grabbing these headlines, we wanted to know much more than just how many—as in, “How many Americans believes in health conspiracies?” We wanted to answer many other “how” questions, too. How do these beliefs spread? How do they correlate with people’s health behaviors? How should providers and others approach treating and talking to those who hold these beliefs?
>>What can medical conspiracy theories tell us about improving health and health care? A lot, as you’ll hear in this conversation between RWJF's Brian Quinn and University of Chicago political scientist Eric Oliver.
It’s important to note that this study’s authors did not set out to pass judgment on these controversial narratives—or those who hold them. In fact, it was critical to the researchers’ success that they remain agnostic in that regard. The bottom line is nearly half of Americans believe in at least one health conspiracy, such as the government is hiding evidence that cell phones cause cancer or the U.S. Food and Drug Administration is intentionally suppressing natural cures for cancer. And, if we are serious about building a Culture of Health, we cannot afford to ignore the perspective of one in every two Americans.
I recently enjoyed a fascinating conversation with the study’s lead researcher, University of Chicago political scientist Eric Oliver, and came away with a few such insights that should enlighten—and may even surprise—some of you.
Caring for the millions of people acquiring health coverage under the Affordable Care Act will require many more primary care providers than are currently available. At a session today on New Models and Workforce Innovations for Primary Care Access at the 2014 National Health Policy Conference convened by AcademyHealth, presenters talked about emerging specialists for primary care, including nurses, physician assistants and care coordinators, who are also known as community health workers.
Pharmacists are also included in that provider model. Jeffrey Kang, MD, MPH, senior vice president of health and wellness at Walgreens, presented data on a model program the pharmacy chain has at more than a dozen hospitals which is helping reduce hospital readmissions. Walgreens has pharmacies at dozens of hospitals across the United States and with its pilot program, called WellTransitions, works with hospital discharge staff on medicine instructions and then follows up with phone calls once patients are home.
Kang said a key question is whether someone is taking the right medicine. In the medication orders system there is no procedure, other than patient initiative, for stopping a previously prescribed medication. For example, if a patient had been taking a blood pressure medication before a hospital stay and then is prescribed a new one in the hospital, they may still have vials of the drug at home, and studies show they commonly continue taking the drug, either instead of, or in addition to the drug prescribed during the recent hospital stay.
With the WellTransitions program, drugs are delivered to the patient before discharge, avoiding a trip to the pharmacy, and pharmacists follow up at 9 days and 25 days.
Walgreens launched the program in 2012 and released data late last year that showed that early results indicate that within the first 6 months that WellTransitions was operational in five hospitals, the 30-day readmission rate for patients in the program was 9.4 percent, compared with 14.3 percent for patients not participating in the program.